Core Scientific, Inc./tx (CORZW) stock
CORZWNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZZ
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$6.54−1.23 (-15.83%)
Close on Oct 30, 2026Market cap $4.26BP/E –Yield –
Core Scientific operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Core Scientific's operating income for the twelve months ending Jun 30, 2026 was -$561.16M. For fiscal 2025 it was -$245.59M. The highest annual figure on record is $131.49M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$245.59M | – |
| FY2024 | Dec 31, 2024 | -$142.07M | -1685.4% |
| FY2023 | Dec 31, 2023 | $8.96M | – |
| FY2022 | Dec 31, 2022 | -$2.11B | -1704.3% |
| FY2021 | Dec 31, 2021 | $131.49M | – |
| FY2020 | Dec 31, 2020 | -$6.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$78.47M | – |
| Q1 FY2026 | Mar 31, 2026 | -$310.42M | – |
| Q4 FY2025 | Dec 31, 2025 | -$117.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$54.79M | – |
| Q2 FY2025 | Jun 30, 2025 | -$26.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$47.04M | -185.2% |
| Q4 FY2024 | Dec 31, 2024 | -$65.39M | -1762.2% |
| Q3 FY2024 | Sep 30, 2024 | -$41.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$90.68M | -1057.7% |
| Q1 FY2024 | Mar 31, 2024 | $55.23M | +626.5% |
| Q4 FY2023 | Dec 31, 2023 | $3.93M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.04M | – |
| Q2 FY2023 | Jun 30, 2023 | $9.47M | – |
| Q1 FY2023 | Mar 31, 2023 | $7.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$636.08M | -722.6% |
| Q3 FY2022 | Sep 30, 2022 | -$401.37M | -8489.9% |
| Q2 FY2022 | Jun 30, 2022 | -$1.05B | -6833.1% |
| Q1 FY2022 | Mar 31, 2022 | -$26.72M | -396.0% |
| Q4 FY2021 | Dec 31, 2021 | $102.16M | – |
| Q3 FY2021 | Sep 30, 2021 | $4.78M | – |
| Q2 FY2021 | Jun 30, 2021 | $15.53M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.03M | – |